Item 305 Quantitative Market Risk Disclosure: 2026 Compliance Walkthrough

If your team is preparing or reviewing the market risk section of a 10-K or 20-F, this guide is for you. Item 305 of Regulation S-K (17 CFR 229.305) is one of the least understood disclosure items in SEC reporting, and in 2026, with interest rate volatility, a weaker dollar, and commodity price swings all running hot, it is also one of the most scrutinized.

This walkthrough covers every decision your team faces: which of the three quantitative methods to use, how to structure qualitative disclosures, when a 10-Q update is mandatory, and the specific comment letter patterns that will get your filing flagged.

Key takeaway: Item 305 is not a derivatives-only rule. It covers all financial instruments, derivative commodity instruments, and other positions sensitive to interest rate, FX, commodity, or equity price changes. Many teams still treat it as a hedge accounting footnote. That is a mistake.

What Does Item 305 Actually Require?

Item 305 requires registrants to provide, in their reporting currency, quantitative information about market risk as of the end of the latest fiscal year, plus qualitative context about how those risks are managed. As the SEC's own rule text states, the disclosures are "intended to clarify the registrant's exposures to market risk associated with activities in financial instruments, derivative commodity instruments, and other market risk sensitive instruments."

The four market risk categories that must be covered, to the extent material, are:

• Interest rate risk (fixed-rate debt, floating-rate borrowings, interest rate swaps)
• Foreign currency exchange rate risk (FX forwards, cross-currency swaps, foreign-currency receivables and payables)
• Commodity price risk (fuel hedges, raw material contracts, commodity derivatives)
• Equity price risk (equity investments, equity-linked compensation instruments)

A point practitioners frequently miss: the scope is broader than derivatives. Fixed-rate long-term debt, foreign-currency-denominated receivables, and unhedged commodity purchase commitments are all "market risk sensitive instruments" if their value changes in response to market rate or price movements. The SEC staff FAQ is explicit on this.

The rule also requires you to separate instruments into trading portfolios and non-trading (other than trading) portfolios before applying any of the three quantitative methods. This distinction matters because the level of disclosure differs: VaR disclosures for trading portfolios, for example, must include a comparison of actual trading results to VaR estimates to assess model accuracy.

Who Must Comply with Item 305?

Item 305 applies to all domestic registrants required to provide MD&A, except small reporting companies (SRCs). The 2020 Regulation S-K modernization (Release No. 33-10825, effective February 10, 2021) formally codified the SRC exemption in the updated framework, replacing the older "small business issuer" carve-out from Regulation S-B.

Registered investment companies are not subject to Regulation S-K and therefore fall outside Item 305 entirely.

For foreign private issuers, the equivalent is Item 9A of Form 20-F. The SEC staff FAQ confirms the substantive requirements are the same as Item 305, with one important exception: foreign private issuers filing under Item 17 of Form 20-F (rather than Item 18) are not subject to the market risk disclosure requirements.

The Three Quantitative Disclosure Alternatives: Which Should You Choose?

This is the decision most teams find hardest, and it is the gap every other guide leaves open. The rule gives you three options, and you can mix and match across risk categories and portfolio types. Here is how each works in practice.

Alternative 1: Tabular Presentation

Tabular presentation requires fair values of market-risk-sensitive instruments and contract terms sufficient to determine future cash flows, organized by expected maturity date.

In practice, this means a multi-column table showing, for each instrument category, the notional or principal amount maturing in each of the next five years plus a "thereafter" bucket, with the corresponding weighted-average rate or price and fair value. Think of a debt maturity schedule crossed with a rate sensitivity table.

Best for: Companies with straightforward, fixed-rate or floating-rate debt structures and limited derivatives. A manufacturer with a term loan, a revolving credit facility, and a handful of FX forwards can produce a clean, readable tabular disclosure. The table is also the most comparable format across companies, which investors appreciate.

Watch out for: Complexity. If your instrument portfolio spans multiple currencies, variable maturities, and embedded optionality, the table becomes unwieldy and may actually obscure more than it reveals. The SEC staff has noted that tabular disclosures can fail to reflect net market risk exposures when instruments offset each other.

Alternative 2: Sensitivity Analysis

Sensitivity analysis expresses the potential loss in future earnings, fair values, or cash flows from selected hypothetical changes in market rates or prices over a selected time period.

This is the most commonly used method among S&P 500 companies, particularly for interest rate risk. A typical disclosure reads: "A hypothetical 100 basis point parallel shift in the yield curve would increase/decrease the fair value of our fixed-rate debt by $X million" or "would reduce net interest income by $Y million over the next 12 months."

Best for: Companies that want flexibility in framing their exposure and whose risk profile is best understood through scenario impact rather than static fair values. It is also the most intuitive format for investors who want to know "what happens if rates move?"

The critical judgment call: You must select a hypothetical change that is "reasonably possible in the near term." The SEC staff FAQ is clear that selecting an unrealistically small shock to minimize apparent exposure is a disclosure quality problem. In 2026, with the Fed funds rate having moved over 500 basis points since early 2022, a 100 bps shock scenario is defensible for most companies, but teams should document why they chose their specific scenario and confirm it reflects current market conditions, not the low-volatility environment of 2020.

For FX risk, the dollar index fell roughly 10.8% in the first half of 2026. If your prior 10-K stated that a hypothetical 10% move in the dollar would not have a material effect, you need to revisit that statement before your next filing. The Corporate Counsel blog noted in July 2025 exactly this scenario as a live 10-Q risk.

Watch out for: Year-over-year consistency. If you change the shock scenario (say, from 100 bps to 200 bps), you must explain why. If you change the metric (from fair value impact to earnings impact), same obligation.

Alternative 3: Value-at-Risk (VaR)

VaR disclosures must state the VaR figure for each market risk category, the model used (historical simulation, Monte Carlo, or variance-covariance), key assumptions including holding period and confidence level, and the limitations of the model.

For trading portfolios specifically, you must also compare actual trading results to VaR estimates to assess model accuracy.

Best for: Financial institutions, broker-dealers, and companies with active trading desks that already compute VaR internally for risk management. If your treasury team runs VaR daily, disclosing it externally adds little incremental cost and gives sophisticated investors the metric they already expect.

Watch out for: VaR is the most technically demanding option and the hardest to explain to a non-specialist investor. It also requires the most disclosure about model assumptions and limitations. For a non-financial company with a simple interest rate hedge program, VaR is almost certainly the wrong choice.

Comparison Table: Choosing Your Method

You may use different alternatives for different risk categories. A company could use tabular for interest rate risk and sensitivity analysis for FX risk. If you switch methods year-over-year, explain the change.

Item 305 vs. Item 303 (MD&A): What Goes Where?

This is a persistent source of confusion. The SEC staff FAQ draws the line clearly: "Item 305 requires more information than Item 303 because it requires specific descriptive and quantitative disclosures about losses from market risk associated with changes in interest rates, foreign currency exchange rates, commodity prices, and equity prices."

Item 303 (MD&A) requires a narrative discussion of known trends and uncertainties that could affect results. Item 305 requires specific quantitative disclosures. They are complementary, not duplicative.

In practice:

• Item 303 MD&A: Discuss the business context. "Our floating-rate debt exposure increased in 2025 following the refinancing of our term loan. We expect continued rate volatility to affect interest expense in 2026."
• Item 305: Quantify it. "A hypothetical 100 basis point increase in SOFR would increase annual interest expense by approximately $12 million based on our $1.2 billion floating-rate borrowings outstanding at December 31, 2025."

One of the most common SEC comment letter themes is inconsistency between Item 305 quantitative disclosures and the Item 303 narrative. If your MD&A says FX risk is a significant concern but your Item 305 sensitivity table shows minimal impact, expect a comment.

For a deeper look at how interest rate risk flows through the 10-Q specifically, see Finrep's companion piece on what your Q2 2026 10-Q must say about interest rate risk.

Qualitative Disclosures Under Item 305(b)

Item 305(b) requires three things: a description of your primary market risk exposures at period end, how you manage those exposures (objectives, general strategies, instruments used), and any material changes in exposures or risk management strategies compared to the prior year.

The qualitative section is where boilerplate is most dangerous. If your company's FX exposure profile changed materially because you entered a new market or restructured your hedging program, the qualitative section must reflect that. Copying prior-year language verbatim when conditions have changed is a comment letter waiting to happen.

Structure the qualitative section to complement, not repeat, the quantitative disclosure. If your sensitivity table shows a $15 million earnings impact from a 100 bps rate move, the qualitative section should explain the strategy behind that exposure: why you carry floating-rate debt, whether you hedge it, and whether that strategy changed.

Safe Harbor Provisions Under Item 305(d)

This is the most overlooked protection in the rule. Item 305(d) provides a safe harbor under the Private Securities Litigation Reform Act (PSLRA) for forward-looking information in Item 305 disclosures, provided the information is identified as forward-looking and accompanied by meaningful cautionary statements.

Sensitivity analysis and VaR disclosures are inherently forward-looking. A sensitivity analysis showing the hypothetical impact of a 100 bps rate move is a projection, not a historical fact. The PSLRA safe harbor protects that projection from private securities litigation if you:

1. Identify the disclosure as forward-looking (a standard legend works).
2. Include meaningful cautionary language about the assumptions and limitations of the model.
3. Do not make the statement with actual knowledge that it is false or misleading.

Many teams are either unaware of this protection or so cautious about it that they add excessive hedging language that undermines the disclosure's usefulness. The right approach is a clean, specific forward-looking identification statement plus a brief description of the key assumptions and their limitations.

When Must You Update Item 305 in a 10-Q?

You do not need to include Item 305 disclosure in every Form 10-Q. Under Item 305(c), the obligation triggers only when there have been material changes in quantitative and qualitative information about market risk since the end of the most recently completed fiscal year.

If there are no material changes, you can state that and move on. If there are material changes, you must provide full discussion and analysis so investors can assess the sources and effects of those changes.

The judgment call is what counts as "material." In 2026, the following scenarios almost certainly require an update:

• Your floating-rate debt balance changed significantly through new borrowings or repayments.
• You entered, terminated, or restructured a material hedging program.
• The dollar moved 10%+ against a currency that is material to your revenue or cost base.
• Commodity prices moved materially and you have unhedged exposure.
• You added or exited a business line with a different market risk profile.

For companies with FX exposure, the dollar's roughly 10.8% decline against major currencies in the first half of 2026 is exactly the kind of move that should trigger a fresh look at whether prior-year sensitivity statements remain accurate.

Common SEC Comment Letter Themes on Item 305

Based on SEC EDGAR comment letter filings from 2023 through 2026, the staff's most frequent Item 305 criticisms are:

1. Boilerplate disclosures that do not reflect the company's actual risk profile. The staff expects disclosures to be company-specific, not generic.
2. Failure to update interim disclosures when market conditions change materially from the annual filing.
3. Inadequate description of hypothetical assumptions in sensitivity analysis, including failure to explain why the chosen shock scenario is "reasonably possible in the near term."
4. Failure to separately present material risk categories. If both interest rate risk and FX risk are material, they must be disclosed separately, not aggregated.
5. Inconsistency between Item 305 and Item 303 MD&A. Quantitative disclosures that contradict or are unexplained by the narrative discussion draw comments.

A practical defense against all five: treat your Item 305 disclosure as a live document that gets updated each quarter, not a boilerplate section that gets rolled forward.

Item 305 and Climate-Related Financial Risk: An Unresolved Gap

The SEC's climate disclosure rule (Release No. 33-11275, adopted March 2024, currently subject to a judicial stay as of mid-2026) requires disclosure of material climate-related risks and their financial impacts. IFRS S2 (Climate-related Disclosures), effective for annual periods beginning on or after January 1, 2024, requires quantitative scenario analysis for climate risks.

Here is the gap: physical and transition climate risks increasingly manifest as commodity price risk (carbon pricing, energy costs), interest rate risk (stranded asset repricing), and asset value risk. These are squarely within Item 305's four risk categories. Yet neither the SEC nor the ISSB has formally addressed whether climate-related commodity price risk or transition risk should be captured within the Item 305 framework or addressed separately.

For companies subject to both frameworks, the practical answer in 2026 is to address climate-related financial risks in both places if they are material as market risks: in Item 305 to the extent they affect the value of market-risk-sensitive instruments, and in the climate disclosure section (or IFRS S2 report) for the broader strategic and scenario analysis. Do not assume that disclosing climate risk in one section satisfies the other.

For foreign private issuers navigating both Item 9A and IFRS 7 (Financial Instruments: Disclosures), note that IFRS 7 paragraphs 31 to 42 require sensitivity analysis for interest rate, currency, and other price risk. IFRS 7-compliant disclosures can serve as the basis for Item 9A compliance, but must be reviewed to confirm they meet the SEC's specific requirements.

What Changed in the 2020 and 2022 Amendments?

The eCFR timeline for 17 CFR 229.305 shows three amendment dates: March 26, 2020; March 31, 2020; and May 31, 2022. The most significant change came from the SEC's broader Regulation S-K modernization (Release No. 33-10825), which formally codified the small reporting company exemption within the updated Regulation S-K framework. Prior to this, SRCs were exempt as "small business issuers" under the separate Regulation S-B, which was rescinded. The 2022 amendment reflects further technical updates. The core structure of Item 305, including the three disclosure alternatives and the four risk categories, is unchanged from the original 1997 rulemaking.

A Note on Why This Rule Exists

Item 305 was adopted on January 28, 1997, as part of Securities Act Release No. 7386, published in the Federal Register on February 10, 1997. The rulemaking was a direct response to high-profile derivatives losses in the mid-1990s, including Procter and Gamble, Orange County, and Barings Bank. The SEC concluded that investors lacked the information needed to assess how companies' market risk exposures could affect financial results. That original purpose, giving investors meaningful and comparable information about market risk, is exactly why boilerplate disclosures draw comment letters: the staff knows what a real disclosure looks like.

FAQ

What are the four types of market risk under Item 305? Interest rate risk, foreign currency exchange rate risk, commodity price risk, and equity price risk. Registrants must present separate quantitative information for each category to the extent it is material.

Which issuers are exempt from Item 305? Small reporting companies (formally exempted by Release No. 33-10825, effective February 2021), registered investment companies, and foreign private issuers filing under Item 17 of Form 20-F.

Does Item 305 apply only to derivatives? No. It covers all financial instruments, derivative commodity instruments, and other positions whose value changes in response to market rates or prices. Fixed-rate long-term debt and foreign-currency receivables are both in scope.

How do I choose between the three quantitative disclosure alternatives? Sensitivity analysis is the most common choice for non-financial companies because it is flexible and investor-friendly. Tabular presentation works well for simple, fixed-rate portfolios. VaR is best reserved for companies with active trading desks that already compute it internally. You can use different methods for different risk categories.

When must I update Item 305 in a 10-Q? Only when there have been material changes in quantitative and qualitative market risk information since fiscal year-end. If no material changes occurred, a statement to that effect satisfies the requirement.

What is the safe harbor under Item 305(d)? Forward-looking information in Item 305 disclosures, such as sensitivity analysis projections, is protected from private securities litigation under the PSLRA if the information is identified as forward-looking and accompanied by meaningful cautionary statements about assumptions and limitations.

How does Item 305 relate to IFRS 7 for foreign private issuers? Item 9A of Form 20-F is the FPI equivalent of Item 305. IFRS 7 paragraphs 31 to 42 require similar sensitivity analysis disclosures. IFRS 7-compliant disclosures can form the basis for Item 9A compliance but must be reviewed against the SEC's specific requirements before filing.